Substantiation of pharmacological correction of the condition of the ocular surface in postcovid syndrome

Introduction. Oxidative stress is a factor in the pathogenesis of postcovid microcirculatory conjunctival disorders. Antioxidant protection preparations are represented by vitamin and mineral complexes and drops that protect cells from free radical oxidation. These include taurine, the active ingredient of which is taurine.

Aim. To evaluate the effectiveness of the effect on the state of the microcirculatory bed of the conjunctiva and the reparative properties of the drug taurine in postcovid syndrome.

Material and methods. The study included 41 patients (82 eyes), in the postcovid period (more than 12 months after the coronavirus infection), divided into 2 groups. The examination consisted of: clinical examination, functional tests (Schirmer test, Norn test, vital dye tests), laser Doppler flowmetry. Treatment: instillation of 0.1% hyaluronic acid, dexpanthenol. Group 1 patients additionally received 4% taurine 3 times a day.

Results and discussion. The effectiveness of therapy was evaluated after 1, 3 and 6 months. The condition of the cornea was monitored weekly for a month. Results: improvement of clinical and functional (decrease in OSDI index, reduction of conjunctival hyperemia, restoration of corneal epithelium) and instrumental indicators (increase in blood flow velocity in vessels of bulbar conjunctiva) in group 1 patients was established after 1 week and 1 month, with preservation of results by 6 months; in patients of group 2 (with less pronounced dynamics) – after 2 weeks and 3 months and moderate suppression of the intensity of the functioning of the regulatory systems of microcirculation by the 6th month of follow-up. Conclusions: due to the cytoprotective and reparative effect on the ocular surface, improvement of the main indicators of microcirculation, the drug can be recommended for use in patients with impaired microcirculation of the conjunctiva and the presence of corneal epitheliopathy in postcovid syndrome.

1. Ulashchik VS. Active oxygen species, antioxidants, and the action of therapeutic physical factors. Voprosy Kurortologii, Fizioterapii, i Lechebnoi Fizicheskoi Kultury. 2013;90(1):60–69. (In Russ.) Available at: https://www.mediasphera.ru/issues/voprosy-kurortologii-fizioterapii-i-lechebnoj-fizicheskoj-kultury/2013/1/030042-87872013111?clear_cache=Y.

2. Шанин ЮН, Шанин ВЮ, Зиновьев ЕВ. Антиоксидантная терапия в клинической практике. СПб.: ЭЛБИ-СПб; 2003. 128 с. Режим доступа: https://www.mmbook.ru/catalog/arhiw/100937-detail.

3. Safonova TN, Zaitseva GV. Pathogenetic mechanisms of dry eye syndrome in a novel coronavirus infection caused by SARS-CoV-2. Russian Open Medical Journal. 2022;11(3):е0306. https://doi.org/10.15275/rusomj.2022.0306.

4. Донцов ВИ, Крутько ВН, Мрикаев БМ, Уханов СВ. Активные формы кислорода как система: значение в физиологии, патологии и естественном старении. В: Крутько ВН. (ред.) Информатика здоровья и долголетия: Сборник трудов ИСА РАН. М.: УРСС; 2006. С. 85–96. Режим доступа: https://studylib.ru/doc/2193956/aktivnye-formy-kisloroda-kak-sistema--znachenie-v.

5. Дубинина ЕЕ. Продукты метаболизма кислорода в функциональной активности клеток (жизнь и смерть, созидание и разрушение): физиологические и клинико-биохимические аспекты. СПб.: Медицинская пресса; 2006. 397 с. Режим доступа: https://www.elibrary.ru/item.asp?edn=qkpvrf.

6. Safonova TN, Zaitseva GV, Kintyukhina NP. The effect of a new coronavirus infection caused by the SARS-CoV-2 virus on microcirculation in the conjunctiva. Meditsinskiy Sovet. 2022;16(14):206–211. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-14-206-211.

7. Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long COVID-an update for primary care. BMJ. 2022;378:e072117. https://doi.org/10.1136/bmj-2022-072117

8. Rosa FT, Freitas EC, Deminice R, Jordao AA, Marchini JS. Oxidative stress and inflammation in obesity after taurine supplementation: a double-blind placebo-controlled study. Eur J Nutr. 2014;53(3):823–830. https://doi.org/10.1007/s00394-013-0586-7.

9. Schaffer SW, Shimada-Takaura K, Jong CJ, Ito T, Takahashi K. Impaired energy metabolism of the taurine-deficient heart. Amino Acids. 2016;48(2):549–558. https://doi.org/10.1007/s00726-015-2110-2.

10. Hultman K, Alexanderson C, Mannerås L, Sandberg M, Holmäng A, Jansson T. Maternal taurine supplementation in the late pregnant rat stimulates postnatal growth and induces obesity and insulin resistance in adult offspring. J Physiol. 2007;579(Pt 3):823–833. https://doi.org/10.1113/jphysiol.2006.124610.

11. Сафонова ТН, Зайцева ГВ, Кинтюхина НП, Медведева ЕС. Способ коррекции микроциркуляторных нарушений при постковидном синдроме. Патент RU 2791660 C1, 13.03.2023. Режим доступа: https://findpatent.ru/patent/279/2791660.html.

12. Safonova TN, At’kova EL, Kintyukhina NP, Reznikova LV. Modern methods of evaluating the morphological and functional state of the eyelids in chronic blepharitis. Vestnik Oftalmologii. 2018;134(5):276–281. (In Russ.) https://doi.org/10.17116/oftalma2018134051276.

13. Luck JC, Kunselman AR, Herr MD, Blaha CA, Sinoway LI, Cui J. Multiple Laser Doppler Flowmetry Probes Increase the Reproducibility of Skin Blood Flow Measurements. Front Physiol. 2022;(13):876633. https://doi.org/10.3389/fphys.2022.876633.

14. Mauritzon S, Ginstman F, Hillman J, Wårdell K. Analysis of laser Doppler flowmetry long-term recordings for investigation of cerebral microcirculation during neurointensive care. Front Neurosci. 2022;(16):1030805. https://doi.org/10.3389/fnins.2022.1030805.

15. Guven G, Dijkstra A, Kuijper TM, Trommel N, van Baar ME, Topeli A et al. Comparison of laser speckle contrast imaging with laser Doppler perfusion imaging for tissue perfusion measurement. Microcirculation. 2023;30(1):e12795. https://doi.org/10.1111/micc.12795.

16. Deegan AJ, Wang RK. Microvascular imaging of the skin. Phys Med Biol. 2019;64(7):07TR01. https://doi.org/10.1088/1361-6560/ab03f1.

17. Surai PF, Earle-Payne K, Kidd MT. Taurine as a Natural Antioxidant: From Direct Antioxidant Effects to Protective Action in Various Toxicological Models. Antioxidants (Basel). 2021;10(12):1876. https://doi.org/10.3390/antiox10121876.

18. He L, He T, Farrar S, Ji L, Liu T, Ma X. Antioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species. Cell Physiol Biochem. 2017;44(2):532–553. https://doi.org/10.1159/000485089.

19. Schaffer SW, Ito T, Azuma J. Clinical significance of taurine. Amino Acids. 2014;46(1):1–5. https://doi.org/10.1007/s00726-013-1632-8.

20. Park SH, Lee H, Park K, Kim HW, Lee DH, Park T. Taurine-induced changes in transcription profiling of metabolism-related genes in human hepatoma cells HepG2. Adv Exp Med Biol. 2006;(583):119–128. https://doi.org/10.1007/978-0-387-33504-9_12.

21. Ramila KC, Jong CJ, Pastukh V, Ito T, Azuma J, Schaffer SW. Role of protein phosphorylation in excitation-contraction coupling in taurine deficient hearts. Am J Physiol. 2015;308(3):H232-H239. https://doi.org/10.1152/ajpheart.00497.2014.

22. Ito T, Miyazaki N, Schaffer S, Azuma J. Potential anti-aging role of taurine via proper protein folding: a study from taurine transporter knockout mouse. Adv Exp Med Biol. 2015;(803):481–487. https://doi.org/10.1007/978-3-319-15126-7_38.

23. Jong CJ, Ito T, Schaffer SW. The ubiquitin-proteasome system and autophagy are defective in the taurine-deficient heart. Amino Acids. 2015;47(12):2609–2622. https://doi.org/10.1007/s00726-015-2053-7.

24. Trachtman H, Futterweit S, Maesaka J, Valderrama E, Fuchs A, Tarectecan AA et al. Taurine ameliorates chronic streptozocin-in duced diabetic nephropathy in rats. Am J Physiol. 1995;269(3 Pt 2):F429–F438. https://doi.org/10.1152/ajprenal.1995.269.3.F429.

25. Ikubo N, Saito M, Tsounapi P, Dimitriadis F, Ohmasa F, Inoue S et al. Protective effect of taurine on diabetic rat endothelial dysfunction. Biomed Res. 2011;32(3):187–193. https://doi.org/10.2220/biomedres.32.187.

26. Murakami S. Role of taurine in the pathogenesis of obesity. MolNutr Food Res. 2015;59(7):1353–1363. https://doi.org/10.1002/mnfr.201500067.

27. Schaffer SW, Azuma J, Mozaffari M. Role of antioxidant activity of taurine in diabetes. Can J Physiol Pharmacol. 2009;87(2):91–99. https://doi.org/10.1139/Y08-110.

28. Basalaj ON, Radkovets AU, Bushma MI. Taurine: a regulator of metabolism and a drug. Meditsinskie Novosti. 2017;(5):3–7. (In Russ.) Available at: https://cyberleninka.ru/article/n/taurin-regulyator-metabolizma-ilekarstvennoe-sredstvo.

29. Safonova TN, Kintyukhina NP. Analyzing the efficacy of conservative versus surgical treatment of chronic mixed blepharitis via laser Doppler flowmetry and interferometry. Russian Open Medical Journal. 2022;11(2):e0212. https://doi.org/10.15275/rusomj.2022.0212.

30. Сафонова ТН, Кинтюхина НП, Сидоров ВВ, Гладкова ОВ. Способ оценки эффективности лечения хронического блефарита методом лазерной допплеровской флоуметрии. Патент RU 2644699 C1, 13.02.2018. Режим доступа: https://patents.google.com/patent/RU2644699C1/ru.